Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Accreditation. Challenging JCAHO.

Matthew Weinstock

    Hospitals & Health Networks
    |February 21, 2006
    PubMed
    Summary
    This summary is machine-generated.

    A new hospital accreditor may challenge The Joint Commission. Hospitals may switch if current accreditation issues are not addressed.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
    Same author

    Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
    Same author

    Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study.

    The Lancet. Oncology·2021
    Same author

    Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model.

    Haematologica·2021
    Same author

    Vaccination as Immunotherapy in Hematologic Malignancies.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2021
    Same author

    Double-Hit and Triple-Hit Follicular Lymphoma.

    American journal of clinical pathology·2020
    Same journal

    Three Different Paths to Clinical Integration.

    Hospitals & health networks·2018
    Same journal

    SERVICE LINE MANAGEET: NOW IT'S CRITICAL Strategies vary, but the goals are the same: Control costs, boost quality: improve the patient experience.

    Hospitals & health networks·2018
    Same journal

    State Medicaid programs are COOKING UP some interesting approaches to reform.

    Hospitals & health networks·2018
    Same journal

    Hospitals Play 'Exctraordmnary' Role.

    Hospitals & health networks·2018
    Same journal

    SmnalL,Rural' +Sart Hospitals take advantage of their size and agility to meet new health care demands. Still, some worry about their ability to remain independent.

    Hospitals & health networks·2018
    Same journal

    TIME IS BRAIN Pioneers hope mobile stroke unit will help save lives and dollars.

    Hospitals & health networks·2018
    See all related articles

    Area of Science:

    • Healthcare Administration
    • Quality Improvement
    • Regulatory Compliance

    Background:

    • The Joint Commission (TJC) is a prominent hospital accreditor.
    • Hospitals face potential dissatisfaction with current accreditation processes.

    Discussion:

    • A new accrediting body presents a competitive alternative.
    • Addressing hospital concerns is crucial for maintaining market share.

    Key Insights:

    • The emergence of a rival accreditor signals potential shifts in the healthcare landscape.
    • Hospital accreditation is a critical factor influencing provider choices.

    Outlook:

    • Hospitals may explore alternative accreditation options.
    • The Joint Commission must adapt to retain its position.